• Abiraterone fresenius kabi

  Form: tablets, film-coated

  Active substance	Dosage
  abiraterone acetate	500 mg

  ATC: L02BX03

• Abiraterone fresenius kabi

  Form: tablets

  Active substance	Dosage
  abiraterone acetate	250 mg

  ATC: L02BX03

• Abiraterone vipharm

  Form: tablets, film-coated

  Active substance	Dosage
  abiraterone acetate	500 mg

  ATC: L02BX03

• Abiraterone zentiva

  Form: tablets, film-coated

  Active substance	Dosage
  abiraterone acetate	500 mg

  ATC: L02BX03

• Anagrelide accord

  Form: capsules, hard

  Active substance	Dosage
  anagrelide	0.5 mg

  ATC: L01XX35

• Anagrelide accord

  Form: capsules, hard

  Active substance	Dosage
  anagrelide	1 mg

  ATC: L01XX35

• Anagrelide vipharm

  Form: capsules, hard

  Active substance	Dosage
  anagrelide	0.5 mg

  ATC: L01XX35

• Anagrelide vipharm

  Form: capsules, hard

  Active substance	Dosage
  anagrelide	1 mg

  ATC: L01XX35

• Ayupil

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  Clozapine	12.5 mg

  ATC: N05AH02

• Ayupil

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  Clozapine	25 mg

  ATC: N05AH02

• Ayupil

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  Clozapine	100 mg

  ATC: N05AH02

• Ayupil

  Form: tablets, dispersible in the oral cavity

  Active substance	Dosage
  Clozapine	200 mg

  ATC: N05AH02

• Celecoxib accord

  Form: capsules, hard

  Active substance	Dosage
  celecoxib	200 mg

  ATC: M01AH01

• Celecoxib accord

  Form: capsules, hard

  Active substance	Dosage
  celecoxib	100 mg

  ATC: M01AH01

• Culbista

  Form: tablets, film-coated

  Active substance	Dosage
  sacubitril sodium	51.2 mg
  valsartan sodium	56.6 mg

  ATC: C09DX04

• Culbista

  Form: tablets, film-coated

  Active substance	Dosage
  Sacubitril sodium	102.4 mg
  Valsartan sodium salt	113.2 mg

  ATC: C09DX04

• Culbista

  Form: tablets, film-coated

  Active substance	Dosage
  Sacubitril sodium	25.6 mg
  Valsartan sodium salt	28.3 mg

  ATC: C09DX04

• Dasatinib viatris

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	140 mg

  ATC: L01EA02

• Dasatinib viatris

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	100 mg

  ATC: L01EA02

• Dasatinib viatris

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	80 mg

  ATC: L01EA02

• Dasatinib viatris

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	70 mg

  ATC: L01EA02

• Dasatinib viatris

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	50 mg

  ATC: L01EA02

• Dasatinib viatris

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	20 mg

  ATC: L01EA02

• Dasatinib zentiva

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	140 mg

  ATC: L01EA02

• Dasatinib zentiva

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	100 mg

  ATC: L01EA02

• Dasatinib zentiva

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	80 mg

  ATC: L01EA02

• Dasatinib zentiva

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	50 mg

  ATC: L01EA02

• Dasatinib zentiva

  Form: tablets, film-coated

  Active substance	Dosage
  dasatinib	20 mg

  ATC: L01EA02

• Donesyn

  Form: tablets, film-coated

  Active substance	Dosage
  donepezil hydrochloride monohydrate	5 mg

  ATC: N06DA02

• Donesyn

  Form: tablets, film-coated

  Active substance	Dosage
  donepezil hydrochloride monohydrate	10 mg

  ATC: N06DA02

• Eltrombopag glenmark

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	50 mg

  ATC: B02BX05

• Eltrombopag glenmark

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	25 mg

  ATC: B02BX05

• Eltrombopag olpha

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	12.5 mg

  ATC: B02BX05

• Eltrombopag olpha

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	25 mg

  ATC: B02BX05

• Eltrombopag olpha

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	50 mg

  ATC: B02BX05

• Eltrombopag olpha

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	75 mg

  ATC: B02BX05

• Eltrombopag polpharma

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	75 mg

  ATC: B02BX05

• Eltrombopag polpharma

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	50 mg

  ATC: B02BX05

• Eltrombopag polpharma

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	25 mg

  ATC: B02BX05

• Eltrombopag polpharma

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	12.5 mg

  ATC: B02BX05

• Eltrombopag sandoz

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	75 mg

  ATC: B02BX05

• Eltrombopag sandoz

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	12.5 mg

  ATC: B02BX05

• Eltrombopag sandoz

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	25 mg

  ATC: B02BX05

• Eltrombopag sandoz

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	50 mg

  ATC: B02BX05

• Eltrombopag zentiva

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	50 mg

  ATC: B02BX05

• Eltrombopag zentiva

  Form: tablets, film-coated

  Active substance	Dosage
  eltrombopag	25 mg

  ATC: B02BX05

• Erlotinib vipharm

  Form: tablets, film-coated

  Active substance	Dosage
  erlotinib	25 mg

  ATC: L01EB02

• Erlotinib vipharm

  Form: tablets, film-coated

  Active substance	Dosage
  Erlotinib	150 mg

  ATC: L01EB02

• Erlotinib vipharm

  Form: tablets, film-coated

  Active substance	Dosage
  Erlotinib	100 mg

  ATC: L01EB02

• Erlotinib zentiva

  Form: tablets, film-coated

  Active substance	Dosage
  erlotinib	150 mg

  ATC: L01EB02